Affiliations
Dana-Farber Cancer Institute collaborates with a variety of hospitals and research institutions to provide our patients with the best possible cancer care.
Clinical Affiliations
Brigham and Women's Hospital
Dana-Farber Cancer Institute and Brigham and Women's Hospital collaborate to provide adult cancer care, with outpatient services at Dana-Farber’s Longwood campus and regional campus locations, and inpatient care at Brigham and Women’s Hospital. Adult patients are cared for in 16 specialized centers focused on different cancer types, where multidisciplinary teams provide coordinated evaluation and treatment.
Dana-Farber Beth Israel Deaconess Cancer Collaboration
In 2026, Dana-Farber will begin the transition to its new clinical collaboration with Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical Faculty Physicians (HMFP).
Dana-Farber Beth Israel Deaconess Cancer Collaboration will give patients the best of both worlds: dedicated cancer care led by Dana-Farber clinicians alongside immediate access to BIDMC’s surgical and other specialty services and affiliated faculty physicians. Together, Dana-Farber and BIDMC — both world-class, Harvard-affiliated teaching hospitals — share a vision for a future-ready model of dedicated cancer care that advances the patient and caregiver experience, expands access to value-driven care, and fosters scientific discovery.
Dana-Farber is also building a new 300-bed inpatient hospital at One Joslin Place, dedicated exclusively to the needs of adult cancer patients.
Dana-Farber/Boston Children's Cancer and Blood Disorders Center
Through a long-standing collaboration between Dana-Farber Cancer Institute and Boston Children's Hospital, outpatient care for children is provided at Dana-Farber's Jimmy Fund Clinic while neighboring Boston Children's Hospital offers inpatient care and pediatric subspecialty consultation. The two institutions function as one to provide a seamless care experience for children with cancer.
The Jimmy Fund Clinic is specifically designed for the comfort and convenience of children with cancer and their families in an outpatient setting. It has a playroom for young children, a separate activities room for teens, spacious exam and procedures rooms, and separate chemotherapy rooms for young children and teens. Private chemotherapy rooms are available for patients at high risk of infection.
Three units at Boston Children's Hospital are dedicated to the inpatient care of children with cancer. A patient activity room is available for young children and teens. Surgery and diagnostic imaging, such as MRI and CT scans, are also provided at Boston Children's Hospital.
Research Affiliations
Harvard Cancer Consortium
Harvard Cancer Consortium (HCC) is an NCI-designated comprehensive cancer center that brings together the cancer research activities and shared resources of Harvard-affiliated institutions. Its members include five Boston academic medical institutions — Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Massachusetts General Hospital, and Dana-Farber Cancer Institute — as well as Harvard Medical School and the Harvard T.H. Chan School of Public Health. These institutions collaborate on clinical and basic research, cancer prevention, and the development of treatments and therapies intended to improve patient outcomes.
HCC includes more than 1,100 researchers and provides access to 14 core facilities, including laboratories, equipment, and other shared resources that may be beyond the means of a single investigator or institution to support independently. Its collaborative programs include disease-based research in areas such as breast, gynecologic, leukemia, lymphoma, and prostate cancers. Other programs are organized by research discipline, including data science, cancer immunology, genetics, and experimental therapeutics. In 2000, the National Cancer Institute expanded Dana-Farber Cancer Institute’s comprehensive cancer center designation to include the full Harvard Cancer Consortium.